NPC(SH:600713) Shang Hai Zheng Quan Bao·2026-01-26 19:41Core Viewpoint - The announcement details the unlocking and listing of 4,476,712 shares from the 2021 restricted stock incentive plan of Nanjing Pharmaceutical Group Co., Ltd, which will be available for trading starting January 30, 2026 [2][4][20]. Group 1: Stock Unlocking Details - The total number of shares to be unlocked is 4,476,712, which represents 0.34% of the company's total share capital [20]. - A total of 324 incentive recipients meet the conditions for unlocking these shares [17][19]. - The unlocking conditions have been met as the third lock-up period has expired, and the company's performance criteria have been achieved [18][19]. Group 2: Incentive Plan Approval and Implementation - The incentive plan was approved by the board on November 29, 2021, and has undergone various procedural steps including public announcements and independent reviews [5][6][7]. - The first grant of restricted stock was registered on January 24, 2022, marking the start of the lock-up periods [18]. - The plan has seen multiple adjustments and reviews, including the repurchase and cancellation of shares from recipients who no longer meet the criteria due to various reasons [9][12][16]. Group 3: Future Implications - The shares will be listed for trading on January 30, 2026, following the completion of the unlocking process [20][21]. - There are specific transfer restrictions for directors and senior management regarding the shares they hold, including limits on annual transfers and conditions post-employment [21][22].